Paragon Biosciences is a dual venture capital firm and incubator that invests in biopharmaceutical startups developing therapeutics for diseases with unmet treatment needs.
Dual venture capital/incubator- Paragon is a dual venture capital firm and incubator that invests in pharmaceutical companies developing therapeutics for diseases with unmet treatment needs. Paragon provides simultaneous funding and strategic resources in order to accelerate the growth of the companies it invests in. The current portfolio includes companies in the following therapeutic areas: dermatology, sleep, cognitive disorders, CNS, immunology, and alzheimer’s. The pipelines of these companies are at various stages of development and include 1 drug that has completed phase III trials.
Castle Creek Pharma-Rare genetic dermatology conditions
Harmony Biosciences-Rare sleep and cognitive disorders
NDA Submission: Narcolepsy
Preclinical: Rare genetic dermatologic conditions, Vitiligo, Tourettes
Paragon could be interested in partnering with technologies that are potential therapeutics for diseases with unmet treatment needs.